The 1st issue of 2021 is online!
This week, we'll share some highlights.
For content alerts https://t.co/PgQbd2OXjq

Letters, conf reports, articles, reviews & commentaries about
https://t.co/SeEu2hfwdT

7 6

Happy to report our study on mutations/amplification in metastatic KRAS amplification likely confers resistance to anti-EGFR therapy. An excellent collaboration between https://t.co/5UztaMBBOT

27 60